PlainRecalls
FDA Drug Critical Class I Terminated

Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.

Reported: July 27, 2022 Initiated: June 27, 2022 #D-1338-2022

Product Description

Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.

Reason for Recall

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Details

Recalling Firm
Loud Muscle Science
Units Affected
500 4-count tins
Distribution
The product was distributed nationwide in the USA and Canada.
Location
Hauppauge, NY

Frequently Asked Questions

What product was recalled?
Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.. Recalled by Loud Muscle Science. Units affected: 500 4-count tins.
Why was this product recalled?
Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 27, 2022. Severity: Critical. Recall number: D-1338-2022.